An antibiotic developed in the 1950s and largely supplanted by newer drugs, effectively targets and kills cancer cells with a common genetic defect, laboratory research by […]
A device that helps desperately sick patients breathe and costs just £150 ($212) to manufacture could revolutionize access to life-saving care in low to middle income countries.